STAT
OCTOBER 31, 2023
Nearly six weeks after his surgery, the world’s second recipient of a genetically modified pig heart has died, the University of Maryland announced Tuesday. Lawrence Faucette, a 58-year-old resident of Frederick, Md., with terminal heart disease, died Monday. He had received the experimental xenotransplant on September 20 at the University of Maryland Medical Center in an eight-hour operation.
PharmaVoice
OCTOBER 31, 2023
Roivant CEO Matt Gline and Telavant CEO Frank Torti know Roivant’s position as buyers and sellers in the pharma industry, and they’re embracing those opportunities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 31, 2023
Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House of Usher.” “W atch “ The Fall of the House of Usher” on Netflix when you can. F**cking Great! Totally based on the Sacklers—Fictional obviously but so damn good!
PharmaVoice
OCTOBER 31, 2023
In the role of interim CEO of Wisp, Monica Cepak aims to break down barriers and expand access via telehealth.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 31, 2023
The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made by Vertex Pharmaceuticals and CRISPR Therapeutics. Tuesday’s meeting is set up a bit differently than most FDA advisory panels. The agency has not raised any concerns about exa-cel’s efficacy or safety, and there will not be a typical vote at the end of the day on whether the data from exa-cel’s pivotal clinical trial
BioPharma Dive
OCTOBER 31, 2023
The high-profile meeting focused on the theoretical risks of CRISPR gene editing, as both the FDA and its advisory committee appeared convinced by the efficacy of the companies’ exa-cel treatment.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
OCTOBER 31, 2023
Expert advisers are reviewing the companies’ case for approval of what could be the first medicine based on the gene editing technology. Follow their discussion here.
STAT
OCTOBER 31, 2023
Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease. The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players.
Pharma Times
OCTOBER 31, 2023
Around 400,000 eligible patients are set to benefit from the travel offer - News - PharmaTimes
STAT
OCTOBER 31, 2023
This article was adapted from STAT’s latest report , “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” C linical trials of newly developed drugs often don’t work out.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
OCTOBER 31, 2023
A new chief pharmacy officer and deputy registrar has been appointed at the General Pharmaceutical Council (GPhC) to help provide pharmacy leadership across the organisation and ‘influence progress at an exciting and challenging time’ for the profession. Roz Gittins has been announced as the new chief pharmacy officer and deputy registrar of the GPhC, while […] The post GPhC announces new executive appointees appeared first on The Pharmacist.
STAT
OCTOBER 31, 2023
Often, workplace conversations about burnout put the onus on the individual to take care of their mental health while ignoring management’s role in solving the problem. A new anti-burnout campaign from the Centers for Disease Control and National Institute for Occupational Safety and Health avoids this typical — and often frustrating — tactic, instead imploring leaders to better support health care workers.
Drug Patent Watch
OCTOBER 31, 2023
Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting… The post New patent for Astrazeneca drug CALQUENCE appeared first on DrugPatentWatch - Make Better Decisions.
STAT
OCTOBER 31, 2023
As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group argues the agency should factor in controversial patent maneuvers for one drug that will have cost the program nearly $2 billion in additional spending by 2026. At issue is the Enbrel medication sold by Amgen for treating rheumatoid arthritis and other ailments.
PharmExec
OCTOBER 31, 2023
In the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
STAT
OCTOBER 31, 2023
Read in English | Leer en inglés. D urante 40 años, los investigadores han intentado sin éxito explicar –o desacreditar– la “paradoja hispana”, es decir, la constatación de que los hispanoamericanos viven varios años más que los estadounidenses blancos por término medio, a pesar de disponer de ingresos y atención sanitaria mucho menores, y mayores tasas de diabetes y obesidad.
The Pharmacist
OCTOBER 31, 2023
Pharmacy teams in all settings, but particularly those in primary care, need guidance on making the best use of skill mix, the International Pharmaceutical Federation (FIP) has said. It called for tools such as a competency development framework to support the development of ‘a range of progressive roles for pharmacists’, including within preventive healthcare and […] The post FIP calls for guidance on optimising skill mix appeared first on The Pharmacist.
STAT
OCTOBER 31, 2023
The world’s hottest summer on record is now bleeding into the fall. Instead of enjoying a cool respite from the heat, millions of Americans started September enduring temperatures so high that schools were forced to close across the country. Extreme heat continued into October, leading organizers to cancel the Twin Cities Marathon due to a forecasted high of 91 degrees — 25 degrees higher than normal for Minneapolis and St.
Express Pharma
OCTOBER 31, 2023
Zydus Lifesciences, through its wholly owned subsidiary Zydus Pharmaceuticals UK, announced the acquisition of the UK headquartered LiqMeds Group of companies which has capabilities and specialisation in development, manufacturing and supply of oral liquid products for global markets, which it currently commercialises through partners. The group’s subsidiary LM Manufacturing, has an oral liquids manufacturing site at Weedon, Northampton, UK, which supplies products to the US and UK markets.
STAT
OCTOBER 31, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, all. Damian here with disappointing news on a closely watched gene therapy, an interesting deal in genome editing, and the long shadow of biotech’s slump.
Pharma Times
OCTOBER 31, 2023
Researchers reduced 4D-MRI image reconstruction times to 60 seconds - News - PharmaTimes
STAT
OCTOBER 31, 2023
Rise and shine, everyone, another busy day is on the way. We can tell by the early hour the official mascots bounded outdoors to chase their breakfast and the increasing volume of traffic passing by the Pharmalot campus. Moreover, some may also note today is when a parade of odd-looking individuals may knock on your door. Beyond the usual cup of stimulation — our choice today is the seasonal pumpkin spice — this calls for a treat or two.
European Pharmaceutical Review
OCTOBER 31, 2023
Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to results of the year-long ONWARDS 6 Phase IIIa clinical trial, recently published in the Lancet. The study, conducted at 99 sites across 12 countries tested the efficacy and safety of a weekly basal injection of icodec (a long-lasting type of insulin) and compared it to a daily basal injection of insulin degludec in
Express Pharma
OCTOBER 31, 2023
US-based Science magazine has ranked Biocon at No. 8 in 2023 amongst the Top 10 Employers in the global biotech, pharma and biopharma sector. Employees across Biocon and Biocon Biologics participated in the annual Top 20 Employers Survey, which Science magazine has been conducting for over a decade. Biocon has featured on the Science Top Employers list of the world’s pre-eminent pharma, biotech, and biopharma employers for 11 consecutive years, informed a company statement.
Pharmaceutical Technology
OCTOBER 31, 2023
ArriVent Biopharma has received the US FDA's breakthrough therapy designation for furmonertinib to treat non-small cell lung cancer.
Outsourcing Pharma
OCTOBER 31, 2023
It was announced today (October 31), that the US Food and Drug Administration (FDA) has granted permission to proceed with clinical investigations of small molecule treatment, roginolisib.
The Pharmacist
OCTOBER 31, 2023
Mohammed Omar Sarwar’s pharmacy has only delivered a few contraception service consultations so far – but they have all been to young Caucasian women. ‘We haven't seen any diversity within that service,’ Mr Sarwar tells The Pharmacist, despite the fact that ‘the need for contraception is across the board’. Based in what he describes as […] The post Tackling health inequalities: The need for ‘cultural competence’ in all services appeared first on The Pharmacist.
BioPharma Dive
OCTOBER 31, 2023
Already a partner to Verve, the pharma is paying $200 million upfront and investing another $50 million in Beam to acquire option rights to several gene editing programs.
Drug Channels
OCTOBER 31, 2023
Zoinks! It's time for a super-sized Halloween roundup of wicked Drug Channels ’ tales. This month’s tricks and treats: Spooky! CVS Health frightens all but one Humira biosimilar maker away from its formulary. Creepy! The gross-to-net bubble for anti-obesity GLP-1 drugs walks among us. Grotesque! Penn Medicine gorges on the 340B program. Vampiric!
Outsourcing Pharma
OCTOBER 31, 2023
M&G Investments has made a $57 million investment with Swiss-based tech firm, SkyCell and says it is seeking to change the face of international pharma supply chains.
Express Pharma
OCTOBER 31, 2023
Beyond Manufacturing: Broadening Horizons of CDMOS Click to download: November 2023 Digital Magazine The post Express Pharma November 2023 appeared first on Express Pharma.
Outsourcing Pharma
OCTOBER 31, 2023
Integrated drug discovery contract research organization (CRO) Sygnature Discovery has invested Â3.75 million in an Azenta compound management storage system that can also provide customer libraries.
World Pharma News
OCTOBER 31, 2023
Epigenetically active drugs enable the cell to read parts oft he genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the University Hospital Tübingen have now published. These "therapy-induced epitopes" could help the immune system recognize cancer cells.
BioPharma Dive
OCTOBER 31, 2023
The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales.
PharmaTech
OCTOBER 31, 2023
This article addresses new alternatives in industrial refrigeration systems ready to comply with current and future regulations, applicable for both new and existing freeze
Expert insights. Personalized for you.
363 
Let's personalize your content